Tackling Obesity: BioRestorative Therapies Advances with Exosome-Based Stem Cell Treatment in Preclinical Studies
![biorestorative therapies logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/04/biorestorative-logo.png)
Melville, NY – May 8, 2024 – BioRestorative Therapies, Inc. (BRTX), a life sciences company pioneering new developments in biologic solutions, has recently announced a significant enhancement to its preclinical metabolic program. The focus of this advancement is a cutting-edge exosome-based biologic that targets one of the most pervasive public health issues today: obesity. Obesity […]